Tirzepatide Cost: Cheapest Online, Lilly Direct, Insurance & Brand Compared
Tirzepatide pricing in 2026 spans an order of magnitude — from $199/month for compounded telehealth to $1,135/month for brand-name Mounjaro at the pharmacy counter. Below is the math on every legitimate path, sortable.
01 Live cost comparison
Pick your dose and insurance status. The table sorts every major provider from cheapest to most expensive in real time.
Tirzepatide Cost Comparison
Tool · 3 of 3Live monthly pricing across major telehealth providers and brand-name retail. Sorted lowest to highest. Prices reflect compounded tirzepatide unless noted.
| Provider | Type | Monthly | Action |
|---|
*Prices shown are recent published rates and may change. Brand-name retail prices reflect Mounjaro/Zepbound list price without insurance. Compounded tirzepatide is not FDA-approved. MEDVi listed first as Editor's Choice.
02 The three tirzepatide pricing tiers
Strip away the marketing and there are essentially three legitimate ways to pay for tirzepatide in the US, separated by an order of magnitude in monthly cost:
1. Brand retail
$1,086–$1,135 / mo
Zepbound or Mounjaro at any US pharmacy without insurance. The list price.
2. Lilly Direct vials
$349–$499 / mo
Eli Lilly's self-pay program for uninsured patients. Single-dose vials only.
3. Compounded telehealth
$199–$329 / mo
State-licensed compounding pharmacies via telehealth providers. Cheapest legal route.
03 Brand-name Mounjaro & Zepbound
These are the two FDA-approved tirzepatide products. They contain identical active ingredient at identical strengths. Mounjaro is labeled for type 2 diabetes; Zepbound is labeled for weight management and obstructive sleep apnea. The retail list prices are similar — about $1,086–$1,135 per month for any dose.
| Pharmacy | Zepbound 5 mg | Mounjaro 5 mg | Notes |
|---|---|---|---|
| CVS Pharmacy | $1,099 | $1,135 | Standard retail |
| Walgreens | $1,089 | $1,124 | Standard retail |
| Walmart | $1,069 | $1,109 | Slight discount |
| Costco | $1,049 | $1,089 | Cheapest brand retail |
| Sam's Club | $1,055 | $1,094 | No membership required for Rx |
| Independent | $1,090–$1,150 | $1,125–$1,180 | Highly variable |
These are list prices for cash-pay patients. With insurance and prior authorization, your copay can drop to $25–$75/month — but only for plans that actually cover the medication, which excludes most Medicare plans and roughly half of commercial plans.
04 Lilly Direct vials (self-pay)
In 2024, Eli Lilly launched LillyDirect — a direct-to-consumer program selling single-dose Zepbound vials (not the auto-injector pen) at a discounted self-pay price. The vials contain identical tirzepatide; the difference is the delivery format and the price.
| Dose | Lilly Direct price (4-week supply) | Notes |
|---|---|---|
| 2.5 mg | $349 | Starter dose |
| 5 mg | $549 | Reduced from $599 in 2025 |
| 7.5 mg | $549 | Same as 5 mg |
| 10 mg | $549 | Same as 5 mg |
| 12.5 mg | $599 | Higher dose tier |
| 15 mg | $599 | Higher dose tier |
To qualify, you must be uninsured (or insured but without coverage for Zepbound), have a valid prescription, and be willing to use a multi-dose vial with an insulin syringe rather than the pre-filled pen. Lilly will connect you to a telehealth provider if you don't have a prescription.
The catch: at $549–$599/month, Lilly Direct is still about 2–3× the cost of compounded tirzepatide via independent telehealth providers. The brand-name vial offers FDA approval and the assurance of Lilly QC; compounded offers a lower price and a wider provider network. Both are legal.
05 Compounded tirzepatide via telehealth
Compounded tirzepatide is produced by state-licensed compounding pharmacies under USP <797> sterile compounding standards. It's the same molecule, made fresh, dispensed in multi-dose vials, and shipped from a pharmacy to your door after a telehealth provider writes the prescription.
Compounded tirzepatide is not FDA-approved — but it is legal under sections 503A and 503B of the FD&C Act, which allow compounding pharmacies to prepare medications for individual patients with valid prescriptions. The FDA has issued guidance about GLP-1 compounding, and the regulatory landscape continues to evolve. As of April 2026, compounded tirzepatide remains widely available through major telehealth providers.
| Provider | Starting price | Lowest dose | Highest dose | Notes |
|---|---|---|---|---|
| MEDVi | $199/mo | 2.5 mg | 15 mg | Editor's Choice — cheapest legitimate |
| Mochi Health | $249/mo | 2.5 mg | 15 mg | Includes coaching & B12 add-ons |
| Henry Meds | $269/mo | 2.5 mg | 15 mg | Long-standing telehealth, transparent |
| Eden | $296/mo | 2.5 mg | 15 mg | Includes provider messaging |
| Hers | $299/mo | 2.5 mg | 15 mg | Brand-recognized telehealth |
| Ro | $329/mo | 2.5 mg | 15 mg | Premium tier with concierge |
| Brello | $349/mo | 2.5 mg | 15 mg | Higher tier |
Pricing typically scales with dose — 2.5 mg and 5 mg are the cheapest tiers, and 12.5–15 mg may add $30–$80/month at most providers. Some providers bundle vitamin B12 or pyridoxine (B6) into the tirzepatide vial for an additional fee or as a free add-on.
06 Insurance, GoodRx, and the Lilly savings card
Commercial insurance
About 30–40% of large employer commercial plans cover Zepbound for weight loss, almost always with prior authorization (PA) requiring documentation of BMI ≥30 (or ≥27 with a comorbidity), failed lifestyle attempts, and sometimes 3–6 months of supervised weight management. Mounjaro is much more widely covered for type 2 diabetes — coverage approaches 80% of commercial plans.
Typical insured copays:
- Tier 2 generic-equivalent: $25–$50/month
- Tier 3 preferred brand: $50–$100/month
- Tier 4 non-preferred specialty: $100–$300/month
- Coinsurance (% of list): $200–$500/month (most expensive)
Lilly Zepbound Savings Card
Eli Lilly offers a manufacturer copay assistance card. The terms (April 2026):
- Insured + Zepbound covered: as low as $25/month for up to 13 fills/year
- Insured but Zepbound NOT covered: as low as $650/month
- Uninsured / Medicare / Medicaid: not eligible
GoodRx and discount cards
GoodRx coupons typically reduce Zepbound retail by 3–8% — to about $1,000–$1,050/month at major chains. This is still 5× the cost of compounded telehealth and only marginally cheaper than walking into Costco. GoodRx is rarely the right answer for tirzepatide self-pay patients.
Medicare and Medicaid
Medicare does not cover Zepbound for weight loss as of April 2026 (the Inflation Reduction Act exclusion for "weight loss drugs" remains in force). It does cover Mounjaro for type 2 diabetes. Medicaid coverage varies by state. Most uninsured/Medicare patients end up using either Lilly Direct or compounded telehealth.
07 The cheapest tirzepatide path, ranked
For cash-pay patients, the strict cost-only ranking is:
- Compounded telehealth (MEDVi) — $199/mo. Cheapest legal option. Multi-dose vial, requires drawing with syringe.
- Compounded telehealth (Mochi/Henry/Eden) — $249–$296/mo. Same compounded form, slightly higher price for additional features.
- Compounded telehealth (Hers/Ro) — $299–$329/mo. Brand-recognized telehealth, premium pricing.
- Lilly Direct vials — $349–$599/mo. FDA-approved Lilly product in vial form.
- Brand pen at Costco — $1,049–$1,089/mo. Cheapest brand auto-injector retail.
- Brand pen at major chain — $1,089–$1,135/mo. Standard retail.
For insured patients with Zepbound coverage, your best path is usually the Lilly Savings Card at $25/month — that's the lowest absolute price available. But if your plan doesn't cover Zepbound, switch immediately to compounded telehealth.
Get the lowest-cost option ($199/mo).
Compounded tirzepatide via licensed US telehealth and pharmacies. No insurance, no prior auth, no $1,000 retail markup. Editor's Choice pricing.
Start Now→08 Hidden costs to watch for
The published monthly price isn't always the total cost. Things to budget for:
One-time and recurring
- Initial telehealth consult fee: $0–$99 depending on provider. MEDVi typically waives it if you subscribe; some others charge upfront.
- Lab work: A few providers require baseline labs ($30–$120 if not covered by insurance). Most cash-pay providers skip this for the basic indication.
- Shipping: Usually free. Cold-pack shipping is included by all major providers.
- Syringes & alcohol pads: Most compounders include them. Brand vial users need to buy U-100 insulin syringes separately ($10–$25 for 100).
- BAC water (compounded only): Usually included. If you need to purchase separately, $5–$15 per 30 mL bottle.
Contracts and lock-ins
- Some providers require 3-month commitments — read the fine print before subscribing
- Cancellation policies vary; "easy cancel anytime" is not universal
- Some providers charge restocking fees if you return unused vials
- Auto-renew is the default at most providers — set a calendar reminder before your first renewal if you're trying it out
09 Tirzepatide cost FAQ
In 2026, the cheapest legitimate self-pay option is compounded tirzepatide via telehealth, starting around $199/month at MEDVi. Eli Lilly's direct vials cost $349–$499/month. Brand-name Zepbound at retail pharmacies runs about $1,086/month, and Mounjaro about $1,135/month — making compounded telehealth roughly 80% cheaper.
As of April 2026, MEDVi consistently offers the lowest published self-pay price for compounded tirzepatide, starting at $199/month for the 2.5–5 mg starting doses. Mochi Health, Henry Meds, Hers, and Ro fall in the $249–$329 range. Always verify the current published price on the provider's site before subscribing.
It depends on the brand and your indication. Mounjaro (type 2 diabetes) is widely covered by commercial plans with prior authorization. Zepbound (weight loss) coverage is more limited — about 30–40% of large employer plans cover it as of 2026, almost always with prior authorization. Medicare does not cover Zepbound for weight loss, and Medicaid coverage varies by state.
GoodRx and similar coupon services can lower the brand-name price modestly — typically to $1,000–$1,050/month for Zepbound at major chain pharmacies. This is still 4–5× the cost of compounded tirzepatide and only $30–$80 cheaper than direct retail. For most cash patients, GoodRx is not the most cost-effective option.
Compounded tirzepatide is produced by state-licensed pharmacies under USP <797> sterile compounding standards. The pricing reflects the actual cost of the active pharmaceutical ingredient (a few dollars per dose), USP-grade BAC water, sterile vials, and pharmacy labor. Brand-name pricing reflects R&D recoupment, FDA approval costs, marketing, and patent-protected pricing power. The molecule is identical; the price difference is structural.
Yes — the Lilly Zepbound Savings Card. Eligible commercially insured patients with coverage can pay as little as $25/month. Eligible commercially insured but no coverage patients can pay as little as $650/month. The card is not available to patients on Medicare, Medicaid, or other government programs. Income limits apply.
Costco Pharmacy lists Zepbound at approximately $1,049/month for cash patients (April 2026). Mounjaro is similar. Costco does not require a membership to use its pharmacy in most states. Costco prices are generally 3–5% below CVS/Walgreens but still significantly higher than compounded telehealth.
In order from cheapest to most expensive: (1) Compounded via telehealth ($199–$329/mo), (2) Lilly Direct vials ($349–$499/mo), (3) Brand at retail with GoodRx (~$1,000–$1,050/mo), (4) Brand at retail without coupons ($1,086–$1,135/mo). The first option is roughly 80% cheaper than the last.
Related
How to get online →
Provider walkthrough, qualification, what to expect in the consult.
Provider reviews →
Independent rankings of every major telehealth tirzepatide provider.
Compounded tirzepatide →
Why it's cheaper, how it works, regulatory status.